Page 26 - Time to DeLiver: Getting a Grip on HE report 2015
P. 26
References
1. A merican Association for the Study of Liver 9. Dyson JK, Anstee QM, McPherson S.
Diseases; European Association for the Non-alcoholic fatty liver disease: a practical
Study of the Liver. Hepatic encephalopathy approach to diagnosis and staging.
in chronic liver disease: 2014 practice Frontline Gastroenterol. 2014;5(3):211-18.
guideline by the European Association for
the Study of the Liver and the American 10. T ransplantation of the Liver. Third Edition.
Association for the Study of Liver Diseases. 2015. Edited by Ronald W Busuttil, Goran
J Hepatol. 2014;61(3):642-59. BG Klintmalm. Cited 2015. Available from:
https://books.google.co.uk/books?id=X-
2. A modio P, Del Piccolo F, Pettenò E, et zwHBgAAQBAJ&pg=PA72&lpg=PA72&d-
al. Prevalence and prognostic value of q=organ+allocation+Busuttil+chapter+6&-
quantified electroencephalogram (EEG) source=bl&ots=OHYOYQ_PJq&sig=G5z-
alterations in cirrhotic patients. J Hepatol. cybf_HgYgT3quy5u-
2001;35(1):37-45. VPA1b3y0&hl=en&sa=X&ei=swxvVdCi-
Js6v7AagoYLQBw&ved=0CCsQ6A-
3. N usrat S, Khan MS, Fazili J, et al. EwAg#v=onepage&q=organ%20
Cirrhosis and its complications: evidence allocation%20Busuttil%20chapter%20
based treatment. World J Gastroenterol. 6&f=false. Accessed September 2015.
2014;20(18):5442-60.
11. R omero-Gómez M, Montagnese S, Jalan
4. British Liver Trust. Cirrhosis. Cited 2015. R. Hepatic encephalopathy in patients
Available at: http://www.britishlivertrust. with acute decompensation of cirrhosis
org.uk/liver-information/liver-conditions/ and acute-on-chronic liver failure.
cirrhosis/. Accessed September 2015. J Hepatol. 2015;62(2):437-47.
5. B lachier M, Leleu H, Peck-Radosavljevic 12. S ilva MJ, Rosa MV, Nogueira P, et al. 10
M, et al. The burden of liver disease years of hospital admissions for liver cirrhosis
in Europe: a review of available in Portugal. EASL ILC 2015, April 22–24
epidemiological data. J Hepatol. 2015. Vienna, Austria. Abstract O123.
2013;58(3):593-608.
13. Orr JG, Goel A, Moriarty K, et al.
6. F leming KM, Aithal GP, Solaymani- The impact on hospital resource
Dodaran M, et al. Incidence and utilisation of rifaximin-alpha for hepatic
prevalence of cirrhosis in the United encephalopathy in routine clinical
Kingdom, 1992-2001: a general population- practice: Real world data from seven UK
based study. J Hepatol. 2008;49(5):732-8. liver centres. Poster presented at EASL
ILC 2015, April 22–24 2015. Vienna,
7. C owie BE, Allard N, MacLachlan JH, et Austria. Poster P0168.
al. The global and regional burden of
liver disease, 2013. Poster presented at 14. Morgan MY, In Sherlock’s Disease of
EASL ILC 2015, April 22–24 2015. Vienna, the Liver and Biliary System, 12th ed:
Austria. Poster P1256. Blackwell Publishing Ltd; 2011.
8. S chuppan D, Afdhal NH. Liver Cirrhosis.
Lancet. 2008;371(9615):838-51.
24
